Does no one care about the issue raised in my note below appear incorrect as to who owned the shares that the 8k discloses were sold by Regen? And theoretically, KCL made the sale and GOT THE MONEY. So Regen only got 55k, not $305k Or are these some other 10,000 shares and where did they come from? Strange happenings in OTC Lands!
And David has not confirmed as yet that the transaction actually closed as proposed on April 20.
Does anyone else have concerns or, as shareholders, do we just bury out pretty heads in the sand and go along with vague, misleading filings to the SEC?
As posted on ihub
Craigheish Thursday, 04/22/21 02:45:42 PM
Re: Smilin_B post# 56604 0
Post # of 56942
I keep asking if the CEO issued a press release confirming that the transaction mentioned on the April 7 8K had been finalized.
No knowledgeable responses.
And the 8K I was issued this week in Regen Biopharma’s name yet the shares were issued to KCL, a separate Limited Company, as per the April 8K notice as filed with the SEC.
So who really sold the shares?
Did KCI get the monies and not REGEN?
And yes I know that KCL is a wholly owned subsidiary, but David Koss should be bright enough to state the truth, especially when he reports to the SEC!!
